Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice
- PMID: 9242522
Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice
Abstract
Tissue factor pathway inhibitor (TFPI) is a multivalent Kunitz-type proteinase inhibitor that directly inhibits factor Xa and, in a factor Xa-dependent fashion, produces feedback inhibition of the factor VIIa/TF catalytic complex responsible for the initiation of coagulation. To further define the physiologic role of TFPI, gene-targeting techniques were used to disrupt exon 4 of the TFPI gene in mice. This exon encodes Kunitz domain-1 of TFPI, which is required for factor VIIa/TF inhibition. In mice heterozygous for TFPI gene-disruption, TFPI(K1)(+/-), an altered form of TFPI lacking Kunitz domain-1, circulates in plasma at a concentration approximately 40% that of wild-type TFPI. TFPI(K1)(+/-) animals have plasma TFPI activity approximately 50% that of wild-type mice, based on a functional assay that measures factor VIIa/TF inhibition, and have a normal phenotype. Sixty percent of TFPI(K1)(-/-) mice die between embryonic days E9.5 and E11.5 with signs of yolk sac hemorrhage. The extent of structural abnormalities within the yolk sac vascular system appears to mirror the condition of the embryo, suggesting that the embryonic and extra-embryonic tissues are both responding to same insult, presumably circulatory insufficiency. Organogenesis is normal in TFPI(K1) null animals that progress beyond E11.5, but hemorrhage, particularly in the central nervous system and tail, is evident during later gestation and none of the TFPI(K1)(-/-) mice survive to the neonatal period. The presence of immunoreactive fibrin(ogen) in the liver and intravascular thrombi is consistent with the notion that unregulated factor VIIa/TF action and a consequent consumptive coagulopathy underlies the bleeding diathesis in these older embryos. Human TFPI-deficient embryos may suffer a similar fate because an individual with TFPI deficiency has not been identified.
Similar articles
-
Tissue factor pathway inhibitor gene disruption.Blood Coagul Fibrinolysis. 1998 Mar;9 Suppl 1:S89-92. Blood Coagul Fibrinolysis. 1998. PMID: 9819035 Review.
-
Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces.J Biol Chem. 1993 Apr 25;268(12):8704-10. J Biol Chem. 1993. PMID: 8473315
-
Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat.Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2563-7. doi: 10.1161/01.atv.19.10.2563. Arterioscler Thromb Vasc Biol. 1999. PMID: 10521388
-
Structure and biology of tissue factor pathway inhibitor.Thromb Haemost. 2001 Oct;86(4):959-72. Thromb Haemost. 2001. PMID: 11686353 Review.
-
Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.J Thromb Haemost. 2018 May;16(5):893-904. doi: 10.1111/jth.14000. Epub 2018 Apr 6. J Thromb Haemost. 2018. PMID: 29532595
Cited by
-
Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.J Thromb Haemost. 2016 Oct;14(10):1960-1970. doi: 10.1111/jth.13431. Epub 2016 Sep 17. J Thromb Haemost. 2016. PMID: 27490645 Free PMC article.
-
Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3106-11. doi: 10.1073/pnas.0504240103. Epub 2006 Feb 17. Proc Natl Acad Sci U S A. 2006. PMID: 16488980 Free PMC article.
-
Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life.J Clin Invest. 2002 Jan;109(1):101-10. doi: 10.1172/JCI12119. J Clin Invest. 2002. PMID: 11781355 Free PMC article.
-
Translation of human tissue factor pathway inhibitor-β mRNA is controlled by alternative splicing within the 5' untranslated region.Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):187-95. doi: 10.1161/ATVBAHA.113.302660. Epub 2013 Nov 14. Arterioscler Thromb Vasc Biol. 2014. PMID: 24233486 Free PMC article.
-
Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth.Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):821-6. doi: 10.1161/ATVBAHA.110.220293. Epub 2011 Jan 13. Arterioscler Thromb Vasc Biol. 2011. PMID: 21233452 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous